RxDoctor Payments Data

Kyle Matsumura, MD

Interventional Pain Medicine · Cottonwood Heights, UTNPI 1619907490

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $576 and has fallen 97.1% since, to $17 in 2024. That places this record below the midpoint for interventional pain medicine clinicians in UT, where the typical reported total is $7,299.

$2,331in general payments, 2019–2025

Across 145 payments — averaging $16.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$335
  • Boston Scientific$229
  • Biodelivery Sciences International, Inc.$204
  • Amgen$202
  • Pfizer$195
  • Nevro Corp.$191
  • plus $974 from 27 others

What the payments were for

  • Food & beverage$2,331100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,331 in reported general payments places this provider in the 15th percentile of 26 interventional pain medicine providers in Utah.

See all interventional pain medicine providers in Utah

Medicare billing

Part B allowed, 2024
$17,807
Medicare patients
72
Services billed
123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tramadol Hcl26$409
Oxycodone Hcl20$337
Gabapentin16$306
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$245

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Cottonwood Heights

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →